 Vidarabine Phosphate
"Vidarabine Phosphate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenosine monophosphate analog in which ribose is replaced by an arabinose moiety. It is the monophosphate ester of VIDARABINE with antiviral and possibly antineoplastic properties.
| Descriptor ID |
D001084
|
| MeSH Number(s) |
D03.438.759.646.138.925 D13.695.065.900 D13.695.667.138.925
|
| Concept/Terms |
Vidarabine Phosphate- Vidarabine Phosphate
- Phosphate, Vidarabine
- Arabinofuranosyladenine Monophosphate
- Monophosphate, Arabinofuranosyladenine
- Ara-AMP
- Ara AMP
- 9-(5-O-Phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine
- Adenine Arabinoside Monophosphate
- Monophosphate, Adenine Arabinoside
- Vidarabine Monophosphate
- Monophosphate, Vidarabine
|
Below are MeSH descriptors whose meaning is more general than "Vidarabine Phosphate".
Below are MeSH descriptors whose meaning is more specific than "Vidarabine Phosphate".
This graph shows the total number of publications written about "Vidarabine Phosphate" by people in this website by year, and whether "Vidarabine Phosphate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1985 | 1 | 0 | 1 | | 1989 | 1 | 0 | 1 | | 1994 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Vidarabine Phosphate" by people in Profiles.
-
van Besien K, Kunavakkam R, Rondon G, De Lima M, Artz A, Oran B, Giralt S. Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes. Biol Blood Marrow Transplant. 2009 May; 15(5):610-7.
-
Kilton LJ, Ashenhurst JB, Wade JL, Schilsky RL, Shiomoto G, Blough RR, French SL, Benson AB. Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trial. Invest New Drugs. 1994; 12(2):163-6.
-
Shevrin DH, Lad TE, Kilton LJ, Cobleigh MA, Blough RR, Weidner LL, Vogelzang NJ. Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council Study. Invest New Drugs. 1989 Jul; 7(2-3):251-3.
-
McCann WP, Hall LM, Siler W, Barton N, Whitley RJ. High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine. Antimicrob Agents Chemother. 1985 Aug; 28(2):265-73.
-
Whitley RJ, Tucker BC, Kinkel AW, Barton NH, Pass RF, Whelchel JD, Cobbs CG, Diethelm AG, Buchanan RA. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans. Antimicrob Agents Chemother. 1980 Nov; 18(5):709-15.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|